Biotech Values

[CollinsIR]

Israel-Backed Diagnostic Company Gains US Listing $HOLL

This is tiny but worth noting - given potential of the technology and caliber of those involved, however it still a non-reporting OTC Pink Company

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance

NewStem Formed with Support of The Hebrew University of Jerusalem -

JERUSALEM and BOCA RATON, Fla., July 16, 2018 - Hollywood Media Corp. (OTC Pink:HOLL) (HMC) today announced the strategic transformation of the Company, its management and Board through an initial $2 million investment in Jerusalem, Israel-based NewStem Ltd. and a refocusing of HMC on the substantial commercial potential of NewStem’s novel diagnostic technology which can predict patients’ resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy. Drug resistance is a major cause of treatment failure in cancer chemotherapy, and currently it is only recognized after the first course of treatment has been completed. In nearly 50% of all cancer cases, resistance to chemotherapy already exists in the tumors before initiation of the treatment.


Link to Press Release